Iris Energy (NASDAQ:IREN – Free Report) had its price objective boosted by HC Wainwright from $13.00 to $16.00 in a research ...

Stock analysts at HC Wainwright issued their FY2024 earnings estimates for Immunic in a report issued on Monday, November ...

Fintel reports that on November 26, 2024, HC Wainwright & Co. downgraded their outlook for Cassava Sciences (NasdaqCM:SAVA) ...

Fintel reports that on November 25, 2024, HC Wainwright & Co. downgraded their outlook for Mainz Biomed N.V. (NasdaqCM:MYNZ) ...

Fintel reports that on November 25, 2024, HC Wainwright & Co. initiated coverage of Sarepta Therapeutics (LSE:0L35) with a Sell recommendation. As of November 21, 2024, the average one-year price ...

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of SoundHound AI ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

To access the live webcast of the fireside chat, please visit: https://investor.arbutusbio.com/events-presentations. An archived replay of the webcast will be available on the Arbutus website for a ...

On Tuesday, H.C. Wainwright increased its price target for Bitdeer Technologies Group (NASDAQ: BTDR) to $18.00, up from the previous $17.00, while maintaining a Buy rating on the stock.

On Monday, H.C. Wainwright reaffirmed a Buy rating with a $120.00 price target on shares of Cytokinetics (NASDAQ:CYTK). The firm's endorsement follows presentations at the 2024 American Heart ...

On Tuesday, H.C. Wainwright maintained a Neutral rating for Mawson Infrastructure Group Inc. (NASDAQ: MIGI), following the company's recent production report. Mawson Infrastructure, transitioning from ...